Spectrophotometric method and apparatus for the non-invasive

• US 4,655,225 A
• Filed: 04/18/1985
• Issued: 04/07/1987
• Est. Priority Date: 04/18/1985
• Status: Expired due to Term

• Current Assignee: Kurabo Industries Limited
• Original Assignee: Kurabo Industries Limited
• Inventors: Gross, Daniel, Dahne, Claus
• Primary Examiner(s): Howell, Kyle L.
• Assistant Examiner(s): Hanley, John C.
• Application Number:
  US06/724,667
• Time in Patent Office: 719 Days
• Field of Search: 128/632-634, 128/664-667
• US Class Current: 600/316
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01N 2021/1742 either absorption or reflection
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 21/359 using near infrared light
• CPC Class Codes: G01N 2201/0655 Hemispheres

Abstract

A directive light beam in a wavelength range appropriate for penetrating into body tissues is applied to a portion of a patient'"'"'s body and the energy transmitted or back-scattered by the underlying tissue is analyzed spectrophotometrically for the presence of glucose. Analysis is performed using especially selected bands in the near-infrared region.

Claims

1. A spectrophotometric apparatus for determining the glucose concentration in body tissues transcutaneously and non-invasively, comprising:

(a) a directional optical light source located external to the body, the spectral composition of the beam of light from said source being such that it can penetrate the skin to tissues below;

(b) means for collecting light transmitted or diffusely reflected from said irradiated tissue;

(c) means for detecting and converting into electrical signals light gathered from at least one band with a measuring signal wavelength λ

G of 1575, 1765, 2100 or 2270 + or - 15 nm, typical of the glucose absorption spectrum, and at least one band with a reference signal wavelength λ

R in the range of 1000 to 2700 nm, typical of the absorption spectrum of background tissue containing glucose but in which the absorption of glucose is nil or insignificant; and

(d) means for transforming said electrical signals into data representing glucose determinations.

2. The apparatus of claim 1, further comprising a means for varying continuously or stepwise the incidence angle of said beam of light relative to the body surface, so that the depth under the skin surface wherefrom the light is gathered after absorption is varied.

3. The apparatus of claim 2, wherein said means for varying said incident angle comprises a mirror displacable in reflective relationship with said beam and positioned so that the reflected beam is always directed toward the same point on the skin.

4. The apparatus of claim 1, wherein said collecting means comprises the internal reflective surface of a halfsphere, said surface being coated with gold and/or a layer of barium sulfate containing paint.

5. A spectrophotometric method for the transcutaneous, non-invasive determination of glucose concentrations in body tissues, comprising the steps of:

(a) irradiating a selected body portion with light from a directional optical lamp source;

(b) collecting the resulting luminous energy (I) either transmitted or diffusively reflected by a sample volume of body tissue under the skin of said irradiated body portion, said collected light including at least one band with a measuring signal wavelength λ

G of 1575, 1765, 2100 or 2270 + or - 15 nm, typical of the glucose absorption spectrum, and at least one band with a reference signal wavelength λ

R in the range of 1000 to 2700 nm, typical of the absorption spectrum of background tissue containing glucose but in which the absorption of glucose is nil or insignificant;

(c) converting said collected light into electrical signals IG and IR representing said measuring and reference bands, respectively; and

(d) entering said electrical signals into an electronic computer for transformation into glucose concentrations.

6. The method according to claim 5, wherein a normalizing factor is established from the difference in absorption in said reference band when glucose is present and when glucose is absent or in insignificant quantities, absorbance values for the glucose as measured in said measuring band are normalized with said factor and said normalized values are used for said glucose determination.

7. The method according to claim 6, wherein said reference band corresponds to an isosbestic point selected in the range of 1100 to 1300 nm or in the regions straddling said λ

G bands.

8. The method according to claim 6, wherein the normalizing factor is established by alternately effecting absorption in said reference band first in a portion of body tissue where the amount of glucose is low or insignificant and, second, in a region of tissue in which the glucose concentration is to be analyzed.

9. The method according to claim 5, wherein said IG and IR signals are differentiated with respect to λ

within the area of said measuring and reference bands, respectively, the difference between the differentials being representative of said glucose determination.